z-logo
open-access-imgOpen Access
[Retracted] MicroRNA‑379 acts as a tumor suppressor in non‑small cell lung cancer by targeting the IGF‑1R‑mediated AKT and ERK pathways
Author(s) -
Fangzheng Zhou,
Long Nie,
DaLi Feng,
Siyan Guo,
Renna Luo
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8339
Subject(s) - cancer , oncogene , microrna , protein kinase b , cell cycle , editorial board , cancer research , audience measurement , mapk/erk pathway , suppressor , medicine , biology , oncology , bioinformatics , apoptosis , library science , political science , signal transduction , computer science , genetics , law , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom